Mineralocorticoid receptor antagonists: new extended roles in cardio- and nephroprotection

The article presents the contemporary views of the role of aldosterone in the progression of cardiovascular and renal diseases. It addresses matters related to the efficacy and safety of mineralocorticoid receptor antagonists in patients with chronic heart failure, chronic kidney disease at various...

Full description

Bibliographic Details
Main Authors: A. M. Esayan, A. N. Nimgirova
Format: Article
Language:Russian
Published: Remedium Group LLC 2018-04-01
Series:Медицинский совет
Subjects:
Online Access:https://www.med-sovet.pro/jour/article/view/2357
_version_ 1797841656354963456
author A. M. Esayan
A. N. Nimgirova
author_facet A. M. Esayan
A. N. Nimgirova
author_sort A. M. Esayan
collection DOAJ
description The article presents the contemporary views of the role of aldosterone in the progression of cardiovascular and renal diseases. It addresses matters related to the efficacy and safety of mineralocorticoid receptor antagonists in patients with chronic heart failure, chronic kidney disease at various stages including terminal renal failure, dialysis therapy, and kidney transplantation.
first_indexed 2024-04-09T16:34:51Z
format Article
id doaj.art-cb1364585b634788990b1f867738e4f7
institution Directory Open Access Journal
issn 2079-701X
2658-5790
language Russian
last_indexed 2024-04-09T16:34:51Z
publishDate 2018-04-01
publisher Remedium Group LLC
record_format Article
series Медицинский совет
spelling doaj.art-cb1364585b634788990b1f867738e4f72023-04-23T06:56:57ZrusRemedium Group LLCМедицинский совет2079-701X2658-57902018-04-0105586310.21518/2079-701X-2018-5-58-632333Mineralocorticoid receptor antagonists: new extended roles in cardio- and nephroprotectionA. M. Esayan0A. N. Nimgirova1Pavlov First Saint Petersburg State Medical UniversityPavlov First Saint Petersburg State Medical UniversityThe article presents the contemporary views of the role of aldosterone in the progression of cardiovascular and renal diseases. It addresses matters related to the efficacy and safety of mineralocorticoid receptor antagonists in patients with chronic heart failure, chronic kidney disease at various stages including terminal renal failure, dialysis therapy, and kidney transplantation.https://www.med-sovet.pro/jour/article/view/2357aldosteronemineralocorticoid receptor antagonistsheart failurechronic kidney diseasedialysiskidney transplantation
spellingShingle A. M. Esayan
A. N. Nimgirova
Mineralocorticoid receptor antagonists: new extended roles in cardio- and nephroprotection
Медицинский совет
aldosterone
mineralocorticoid receptor antagonists
heart failure
chronic kidney disease
dialysis
kidney transplantation
title Mineralocorticoid receptor antagonists: new extended roles in cardio- and nephroprotection
title_full Mineralocorticoid receptor antagonists: new extended roles in cardio- and nephroprotection
title_fullStr Mineralocorticoid receptor antagonists: new extended roles in cardio- and nephroprotection
title_full_unstemmed Mineralocorticoid receptor antagonists: new extended roles in cardio- and nephroprotection
title_short Mineralocorticoid receptor antagonists: new extended roles in cardio- and nephroprotection
title_sort mineralocorticoid receptor antagonists new extended roles in cardio and nephroprotection
topic aldosterone
mineralocorticoid receptor antagonists
heart failure
chronic kidney disease
dialysis
kidney transplantation
url https://www.med-sovet.pro/jour/article/view/2357
work_keys_str_mv AT amesayan mineralocorticoidreceptorantagonistsnewextendedrolesincardioandnephroprotection
AT annimgirova mineralocorticoidreceptorantagonistsnewextendedrolesincardioandnephroprotection